Maynard Um
-
-
-
-
-
-
-
Zymeworks secures $250 million in royalty-backed financing from Royalty Pharma
-
-
-
-
-
-
-
TEVA secures $500 million funding from Royalty Pharma for vitiligo drug
-
-
-
-
-
-
-
Royalty Pharma (RPRX) PT Raised to $45 at Goldman Sachs
-
-
-
-
-
-
-
Royalty Pharma provides up to $300 million to Zenas BioPharma for obexelimab
-
-
-
-
-
-
-
Royalty Pharma plc (RPRX) and Revolution Medicines (RVMD) Enter Into Funding Agreements for Up to $2 Billion
-
-
-
-
-
-
-
Royalty Pharma plc (RPRX) Announces R&D Funding Collaboration With Biogen
-
-
-
-
-
-
-
Syndax Pharmaceuticals (SNDX) and Royalty Pharma (RPRX) Enter $350M Royalty Funding Agreement for Niktimvo
-
397,087 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

